Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/19/05 → 05/8/06 |
Funding
- Immunomedics Incorporated: $2,500.00
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Epratuzumab in Patients with Active Systemic Lupus Erythematosus
- Perl, Andras (PI)
- Neupane, Hom (CoPI)
- Phillips, Paul (CoPI)
Project: Research